Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid
Clinical trial NCT01634100 · COMPLETED
Trial details
- NCT number
- NCT01634100
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2012-08-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.